PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.
Ali Merchant, President and CEO, iQ3Connect
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Catherine Havasi, CEO, Luminoso
"Slowing the aging process of aging by tweaking the body’s metabolism", Prof. Leonard P. Guarente, Novartis Professor of Biology, MIT & co-founder, Elysium Health
Max Kanter, Cofounder & CEO, Feature Labs
MIT Academic innovator: "AI killer apps for Energy," Kalyan Veeramachaneni, Principal Research Scientist, MIT Laboratory for Information and Decision Systems
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.
David Shrier, CEO & founder, Distilled Identity
Natan Linder, Founder, Tulip